Clinical Trial Update: Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating IL-12 gene therapy for locally recurrent prostate cancer has completed, with results posted in October 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Interleukin-12 gene therapy (interleukin-12 gene therapy)

Snippet

Sponsor: Henry Ford Health System | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-10-10